Search

everythinglearnresearchcommunity

for

Search:↓

Acyclovir cream may slow down hair growth, suggesting it could be a new treatment for excessive hairiness.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Biodegradable microneedle patches help topical steroids work better for prurigo nodularis.

Topical minoxidil can cause serious heart issues in children.

Excessive scalp massage after using minoxidil can cause hair damage, but reducing massage and using MSC exosomes can help.

The new 5% minoxidil formulation without propylene glycol effectively promotes hair growth with fewer side effects and better user satisfaction.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

The 5% minoxidil lotion without propylene glycol is effective, well-tolerated, and cosmetically acceptable for hair loss.

The finasteride nanogel could be an effective topical treatment for hair loss.

15d‐PGJ2 cream protects against UVB-induced skin damage in mice.

The "After Minoxidil" spray makes hair easier to style, less greasy, and encourages people to keep using the treatment.

Topical minoxidil might potentially cause vision problems, but more research is needed.

Minoxidil is effective in treating various types of hair loss and can improve quality of life, with combination therapies showing increased effectiveness.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Minoxidil and finasteride are the best for non-scarring hair loss; more research is needed for scarring hair loss treatments.

Iron oxide nanoparticles improve skin penetration and drug release for hair loss treatment.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Topical booster improves hair loss treatment effectiveness.

Emulgel improves skin delivery of various drugs better than traditional methods.

Topical ruxolitinib quickly improves non-segmental vitiligo.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

New technologies may improve topical treatments for hair loss.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

Oral and topical finasteride are effective and safe for treating female hair loss.

Topical minoxidil does not block androgen effects.

Nanoemulgel could be a promising new treatment for hair loss.

The 0.25% finasteride solution, when applied once a day, effectively reduces scalp DHT, potentially minimizing sexual side-effects linked to a systemic DHT reduction.

The new drug delivery system releases the drug better in sebum and targets follicles more effectively than the conventional cream.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.